Trial Profile
Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2021
Price :
$35
*
At a glance
- Drugs Dalbavancin (Primary) ; Dalbavancin (Primary)
- Indications Bacterial peritonitis
- Focus Pharmacokinetics
- 02 Mar 2020 Results published in the Antimicrobial Agents and Chemotherapy
- 09 Jul 2019 Status changed from active, no longer recruiting to completed.
- 21 Jun 2018 Status changed from recruiting to active, no longer recruiting.